Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions (Q38254279)

1 September 2017

1 reference

title

Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions (English)

1 reference

1 September 2017

0 references

0 references

1

Erika B Rangel

1 reference

PubMed ID

25255841

1 September 2017

language of work or name

English

0 references

publication date

26 September 2014

1 reference

Expert Opinion on Drug Metabolism & Toxicology

1 September 2017

1 reference

1 September 2017

10

1 reference

1 September 2017

1585-1605

1 reference

1 September 2017

11

1 reference

2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR)

1 September 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

The impact of pancreas and kidney transplant on cardiovascular risk factors (analyzed by mode of immunosuppression and exocrine drainage).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Long-term (5 years) efficacy and safety of pancreas transplantation alone in type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Pancreas transplantation in African American patients using basiliximab induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Minimization and withdrawal of steroids in pancreas and islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Minimization protocols in pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Very early steroid withdrawal in simultaneous pancreas-kidney transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Insulin sensitivity and negative insulin feedback after pancreas transplantation in insulin-dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Metabolic long-term follow-up of functioning simultaneous pancreas-kidney transplantation versus pancreas transplantation alone: insights and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Consequences on beta-cell function and reserve after long-term pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Normalization of hepatic glucose regulation despite systemic insulin delivery. Studies in patients with pancreatic transplantation for Type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Hepatic insulin resistance after pancreas transplantation in type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Incidence of and risk factors for posttransplant diabetes mellitus after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

New-onset diabetes mellitus after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Glucose homeostasis and insulin secretion during chronic treatment with cyclosporin in nondiabetic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Metabolic consequences of pancreatic systemic or portal venous drainage in simultaneous pancreas-kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Effect of venous drainage site on insulin action after simultaneous pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Modified release tacrolimus in de novo immunosuppression after simultaneous pancreas-kidney transplantation--a first single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Cyclic ADP-ribose binds to FK506-binding protein 12.6 to release Ca2+ from islet microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Suppression of the expression of a pancreatic beta-cell form of the kinesin heavy chain by antisense oligonucleotides inhibits insulin secretion from primary cultures of mouse beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Ca2+-dependent dephosphorylation of kinesin heavy chain on beta-granules in pancreatic beta-cells. Implications for regulated beta-granule transport and insulin exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Recovery from diabetes in mice by beta cell regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Five stages of evolving beta-cell dysfunction during progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Calcineurin signaling regulates human islet {beta}-cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

The direct effects of tacrolimus and cyclosporin A on isolated human islets: A functional, survival and gene expression study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Metabolic results 3 years after simultaneous pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Cyclic ADP-ribose in insulin secretion from pancreatic beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Metabolic control of beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Targeted inactivation of kinesin-1 in pancreatic β-cells in vivo leads to insulin secretory deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

A large, prospective, randomized, open-label, multicentre study of corticosteroid withdrawal in SPK transplantation: a 3-year report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Can new-onset diabetes after kidney transplant be prevented?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Risk factors for the development of posttransplantation diabetes mellitus in simultaneous pancreas and kidney recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Rapamycin suppresses the expansion and differentiation of porcine neonatal pancreas cell clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Influence of sirolimus on cyclosporine-induced pancreas islet dysfunction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Complications after pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Significant associations between CCL5 gene polymorphisms and post-transplantational diabetes mellitus in Korean renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Genetics of new-onset diabetes after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Association between 276G/T adiponectin gene polymorphism and new-onset diabetes after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Extreme subcutaneous, intramuscular and inhaled insulin resistance treated by pancreas transplantation alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

beta-cell failure in diabetes and preservation by clinical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

New-onset diabetes after kidney transplantation: prevalence, risk factors, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Early basal insulin therapy decreases new-onset diabetes after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Combined pancreas-kidney transplantation for patients with end-stage nephropathy caused by type-2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas tran

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Single-center, open, prospective, randomized pilot study comparing cyclosporine versus tacrolimus in simultaneous pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Neoral versus prograf in simultaneous pancreas-kidney transplantation with portal venous drainage: three-year results of a single-center, open-label, prospective, randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Corticosteroid withdrawal in simultaneous pancreas-kidney transplantation: a 3-year report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Simultaneous pancreas-kidney transplantation: analysis of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Extended pancreas donor program - the EXPAND study rationale and study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

Impaired Insulin-Stimulated Nonoxidative Glucose Metabolism in Pancreas-Kidney Transplant Recipients: Dose-Response Effects of Insulin on Glucose Turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2014.964205

10.1517/17425255.2014.964205

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25255841